{"title":"Targeting TDP-43-activated GRP78/endoplasmic reticulum stress axis suppresses triple-negative breast cancer progression","authors":"Jiao Wang , Haotian Xu , Li Tang","doi":"10.1016/j.bcp.2025.117331","DOIUrl":null,"url":null,"abstract":"<div><div>The TAR DNA-binding protein-43 (TDP-43), a highly conserved DNA/RNA binding protein encoded by the TARDBP gene, has garnered extensive scientific attention in the realm of neurodegenerative diseases. Notably, its association with malignant tumors has become increasingly apparent in recent years. This investigation aims to examine the role of TDP-43 in triple-negative breast cancer (TNBC) and to clarify the underlying mechanisms. Bioinformatics analysis showed that TDP-43 was substantially up-regulated in breast cancer tissues. Elevated TDP-43 expression stimulated TNBC cell proliferation and migration in vitro, and accelerated tumor progression in vivo. TDP-43 was identified as a promoter of tumor growth, with its inhibition resulting in a significant impediment to cell growth. Additionally, the overexpression of Glucose-regulated protein 78 (GRP78) counteracted the suppressive effect on cell proliferation and migration observed upon TDP-43 knockdown, affirming TDP-43′s critical role in breast cancer cell proliferation and migration. Mechanistic investigations have demonstrated that TDP-43 binds directly to GRP78 mRNA, stimulating its expression. The up-regulation of GRP78, a master regulator of the unfolded protein response, activates the inositol-requiring enzyme 1 alpha (IRE1α) pathway, exacerbating endoplasmic reticulum (ER) stress. Consequently, this process enhances the proliferation and migration of TNBC cells, contributing significantly to tumor progression. Here, we demonstrate that TDP-43 promotes cell proliferation and migration by regulating ER stress in breast cancer, offering valuable insights into the mechanistic intricacies of TDP-43 in TNBC and holding potential implications for precision treatments in this context.</div></div>","PeriodicalId":8806,"journal":{"name":"Biochemical pharmacology","volume":"242 ","pages":"Article 117331"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0006295225005969","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The TAR DNA-binding protein-43 (TDP-43), a highly conserved DNA/RNA binding protein encoded by the TARDBP gene, has garnered extensive scientific attention in the realm of neurodegenerative diseases. Notably, its association with malignant tumors has become increasingly apparent in recent years. This investigation aims to examine the role of TDP-43 in triple-negative breast cancer (TNBC) and to clarify the underlying mechanisms. Bioinformatics analysis showed that TDP-43 was substantially up-regulated in breast cancer tissues. Elevated TDP-43 expression stimulated TNBC cell proliferation and migration in vitro, and accelerated tumor progression in vivo. TDP-43 was identified as a promoter of tumor growth, with its inhibition resulting in a significant impediment to cell growth. Additionally, the overexpression of Glucose-regulated protein 78 (GRP78) counteracted the suppressive effect on cell proliferation and migration observed upon TDP-43 knockdown, affirming TDP-43′s critical role in breast cancer cell proliferation and migration. Mechanistic investigations have demonstrated that TDP-43 binds directly to GRP78 mRNA, stimulating its expression. The up-regulation of GRP78, a master regulator of the unfolded protein response, activates the inositol-requiring enzyme 1 alpha (IRE1α) pathway, exacerbating endoplasmic reticulum (ER) stress. Consequently, this process enhances the proliferation and migration of TNBC cells, contributing significantly to tumor progression. Here, we demonstrate that TDP-43 promotes cell proliferation and migration by regulating ER stress in breast cancer, offering valuable insights into the mechanistic intricacies of TDP-43 in TNBC and holding potential implications for precision treatments in this context.
期刊介绍:
Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.
The journal''s target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.
All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.
While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.